Deficits in reelin levels and a loss of reelin-positive cells are apparent in brain pathologies such as schizophrenia, depression, and epilepsy and this may be accompanied by alterations in the nitrinergic system. The gene discussed is RELN; the disease is depressive symptom measurement.